Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia

BACKGROUND: We examined the safety and efficacy of a treatment protocol containing Favipiravir for the treatment of SARS-CoV-2. METHODS: We did a multicenter randomized open-labeled clinical trial on moderate to severe cases infections of SARS-CoV-2. Patients with typical ground glass appearance on...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int Immunopharmacol
Main Authors: Solaymani-Dodaran, Masoud, Ghanei, Mostafa, Bagheri, Mehdi, Qazvini, Ali, Vahedi, Ensieh, Hassan Saadat, Seyed, Amin Setarehdan, Seyed, Ansarifar, Akram, Biganeh, Hossein, Mohazzab, Arash, Khalili, Davood, Hosein Ghazale, Amir, Reza Heidari, Mohammad, Taheri, Ali, Khoramdad, Maliheh, Mahdi Asadi, Mohammad, Nazemieh, Masoud, Varshochi, Mojtaba, Abbasian, Samaneh, Bakhtiari, Ali, Mosaed, Reza, Hosseini-shokouh, Seyyed-Javad, Shahrokhi, Masoume, Yassin, Zeynab, Ali Zohal, Mohammad, Qaraati, Maryam, Rastgoo, Nafiseh, Sami, Ramin, Javad Eslami, Mohammad, Asghari, Akram, Namazi, Mansoor, Ziaie, Shadi, Jafari-Moghaddam, Raana, Kalantari, Saeid, Memarian, Mohammad, Khodadadi, Javad, Hossein Afshari, Mohammad, Momen-Heravi, Mansooreh, Behzadseresht, Niusha, Reza Mobayen, Ahmad, Mozafari, Abolfazl, Movasaghi, Fatemeh, Haddadzadeh Shoushtari, Maryam, Moazen, Javad
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier B.V. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7951885/
https://ncbi.nlm.nih.gov/pubmed/33735712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107522
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados